Photo of Koichiro Ohashi

Koichiro Ohashi

Koichiro Ohashi is Co-Chair of the Japan Practice and focuses his practice on representing clients in a variety of financial matters, including cross-border and domestic banking, capital market transactions e.g. establishment of sponsored American Deposit Receipt programs, fund and investment management matters (private equities, hedge funds and REITs), and corporate matters (especially in mergers and acquisitions, and restructuring transactions). He is experienced in the Japanese domestic market and represents both Japanese and international financial institutions on numerous types of financial transactions, such as syndicated loans, securitization transactions, derivative transactions, PIPE transactions, mezzanine finance transactions and equity finance transactions.

Koichiro advises various international and domestic fund managers for private equities, hedge funds, and real estate funds in the registration of funds for distribution in Japan and frequently provides advice on the structure of both domestic and offshore funds to be distributed to Japanese investors. He also advises Japanese trust banks and pension funds on their investments into foreign funds and foreign investment regulations.

The Japanese government is aware of the challenges in securing funds for drug development within Japan’s biopharmaceutical startup ecosystem, especially compared to Europe and the United States. The Japan Agency for Medical Research and Development has established a program to support biopharmaceutical startups involved in developing patentable pharmaceuticals and regenerative medicine products and therapeutics.
Continue Reading Japan’s AMED Offers ‘Double Match Up’ Grants for Pharma Startups: Considerations for Investors and Companies